Rewalk Robotics’ (RWLK) “Buy” Rating Reaffirmed at Piper Jaffray Companies

Piper Jaffray Companies reissued their buy rating on shares of Rewalk Robotics (NASDAQ:RWLK) in a research report sent to investors on Sunday morning. Piper Jaffray Companies currently has a $3.00 price objective on the medical device company’s stock.

A number of other equities analysts have also weighed in on RWLK. Jefferies Group lowered their price target on shares of Rewalk Robotics from $8.00 to $5.00 and set a buy rating on the stock in a research report on Friday, November 3rd. Canaccord Genuity restated a buy rating and set a $3.00 price target on shares of Rewalk Robotics in a research report on Monday, November 6th. Zacks Investment Research upgraded shares of Rewalk Robotics from a hold rating to a buy rating and set a $1.50 price target on the stock in a research report on Thursday, November 9th. Finally, Oppenheimer set a $3.00 price target on shares of Rewalk Robotics and gave the stock a buy rating in a research report on Tuesday, December 26th. One equities research analyst has rated the stock with a sell rating, one has issued a hold rating and four have assigned a buy rating to the company’s stock. The stock currently has a consensus rating of Buy and an average target price of $2.83.

Shares of Rewalk Robotics (RWLK) opened at $1.10 on Friday. Rewalk Robotics has a 52-week low of $1.05 and a 52-week high of $3.20. The stock has a market cap of $31.82, a PE ratio of -0.69 and a beta of 0.79. The company has a debt-to-equity ratio of 7.46, a current ratio of 2.02 and a quick ratio of 1.65.

Rewalk Robotics (NASDAQ:RWLK) last announced its earnings results on Thursday, November 2nd. The medical device company reported ($0.22) earnings per share (EPS) for the quarter, beating the Thomson Reuters’ consensus estimate of ($0.32) by $0.10. The business had revenue of $1.70 million for the quarter, compared to analyst estimates of $1.63 million. Rewalk Robotics had a negative net margin of 346.14% and a negative return on equity of 568.25%. The company’s revenue for the quarter was up 21.4% compared to the same quarter last year. During the same quarter last year, the business earned ($0.62) earnings per share. sell-side analysts forecast that Rewalk Robotics will post -1.14 EPS for the current year.

A hedge fund recently raised its stake in Rewalk Robotics stock. Advisor Group Inc. increased its holdings in shares of Rewalk Robotics Ltd (NASDAQ:RWLK) by 1,495.6% during the third quarter, according to its most recent disclosure with the Securities and Exchange Commission. The fund owned 181,900 shares of the medical device company’s stock after acquiring an additional 170,500 shares during the quarter. Advisor Group Inc. owned about 0.82% of Rewalk Robotics worth $264,000 at the end of the most recent reporting period. 3.23% of the stock is owned by hedge funds and other institutional investors.

COPYRIGHT VIOLATION WARNING: “Rewalk Robotics’ (RWLK) “Buy” Rating Reaffirmed at Piper Jaffray Companies” was first reported by Community Financial News and is the property of of Community Financial News. If you are accessing this news story on another domain, it was illegally stolen and reposted in violation of US & international copyright and trademark laws. The original version of this news story can be accessed at

About Rewalk Robotics

ReWalk Robotics Ltd. is a medical device company. The Company is engaged in designing, developing and commercializing exoskeletons that allow individuals with mobility impairments or other medical conditions the ability to stand and walk once again. The Company offers ReWalk, which is an exoskeleton that uses its tilt-sensor technology and an on-board computer and motion sensors to drive motorized legs that power movement.

Analyst Recommendations for Rewalk Robotics (NASDAQ:RWLK)

Receive News & Ratings for Rewalk Robotics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Rewalk Robotics and related companies with's FREE daily email newsletter.


Leave a Reply

share news on Facebook
tweet this investment news
share on linkedin
share on StockTwits
share on Google Plus
share on reddit